Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BECOX: Bevacizumab, Capecitabine, and Oxaliplatin in Elderly Metastatic Colorectal Cancer
NCT01067053Phase 2Unknown
- Sponsor
- GEMCAD
- Start
- Nov 2009
- Primary completion
- Nov 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in colorectal adenocarcinoma, sponsored by GEMCAD. Status: unknown.
02
Drugs
bevacizumab
03
Conditions
colorectal adenocarcinoma
Beyond the preview
Go deeper on NCT01067053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01067053.